Mediastinal germ cell tumor
Frequency (% cases)
Teratoma
43–75
Seminoma
10–37
Yolk sac tumor
2–12
Embryonal carcinoma
2–8
Choriocarcinoma
2
Mature mediastinal teratomas have been described in patients between 1 month and 73-year-olds with a peak incidence in early adulthood (mean 28 years) [33]. On gross examination [33] benign teratomas are usually encapsulated and well circumscribed (Fig. 8.1). The average tumor size is 10.5 cm (range, 2.5–27 cm). Similar to mature teratomas in other locations, cysts might occur within the tumor (Fig. 8.1) [70]. However, in contrast to their gonadal counterpart, monodermal teratomas such as struma ovarii have not been described in the mediastinum.
Fig. 8.1
Mature cystic teratoma. (a) A well-circumscribed mass with smooth borders has focal yellow tissue at the rim. (b) Sectioning reveals a cyst with largely smooth lining and focal small nodular areas. (c) On microscopy, the cyst wall is comprised of fibrous tissue with glandular and cystic areas and thymic parenchyma (upper right). (d) Multiple germ layers are present including the mesoderm (cartilage, adipose tissue) and endoderm (respiratory epithelium (e, f) and pancreatic tissue (f)). This teratoma is in a background of thymic parenchyma (g). The cyst is lined by benign ciliated respiratory epithelium (g). Magnification × 12.5 (c), 20 (d), 200 (e, g), 100 (f), 400 (h)
In contrast to adult gonadal teratomas or congenital/pediatric teratomas, in the adult mediastinum, the distinction between mature and immature teratoma is critical to patient management because immature teratomas have in general a worse prognosis.
At present, there is no grading scheme for extragonadal immature teratomas; however, it has been suggested to report the percentage of immature elements. Teratomas with other malignant germ cell elements (e.g., seminoma, embryonal carcinoma, yolk sac tumor) are regarded as malignant non-seminomatous GCT. Other adverse histologic features include sarcomatous or carcinomatous transformation, or an associated hematologic malignancy (see Chapter 12).
8.6.2 Seminoma
Pure seminomas represent the second most common mediastinal GCT accounting for approximately 10–37 % of all mediastinal GCTs (Table 8.1) [68, 69]. They usually occur in the anterior mediastinum [23, 51]. The vast majority of mediastinal seminomas are identified in men; only rare cases have been reported in women [6, 26, 29, 69, 71, 72]. The reported age ranges between 11 and 79 years with a mean age of 46.5 years in one study [51]; other studies report that the tumor most commonly occurs in the third decade followed by the fourth and second decade [6].
Seminomas vary in size from a few centimeters to over 16 cm in greatest diameter [23]. On gross examination, mediastinal seminomas are usually soft and have a smooth and glistening outer surface or may show a lobulated appearance; the cut surface is coarsely lobular or exhibits a discrete nodular pattern, and the color varies from white to light tan. In some cases, solid areas may alternate with large cystic spaces containing necrotic material, whereas in other areas the tumor may have the appearance of an entirely cystic mass.
Some microscopic features appear to be unique to mediastinal seminomas (Table 8.2) (Fig. 8.2). They frequently involve the thymus, showing cyst formation and thymic epithelial cell hyperplasia [50, 73]. Cystic seminomas may histologically mimic multilocular thymic cysts [50]. These tumors characteristically show areas of lymphoid hyperplasia (Fig. 8.3), cysts lined by squamous epithelium, and cholesterol cleft granulomas. The seminomatous component might be growing along the cystic walls of the tumor making its distinction from thymic follicular hyperplasia or thymoma (Fig. 8.4) difficult. Therefore, a high level of suspicion is necessary in the case of cystic lesions of the thymus, especially if associated with a granulomatous response; extensive sampling of these cystic tumors is critical. Seminomas might be especially difficult to identify in small biopsies from the mediastinum because of cystic changes, and inflammatory and granulomatous response may obscure the diagnostic tumor cells.
Histopathologic features | Frequency (% cases) |
---|---|
Lymphocytic infiltration | 100 |
Fibrous septa/stroma | 91 |
Prominent tumor cell nucleoli | 91 |
Clear tumor cell cytoplasm | 87 |
Distinct tumor cell borders | 87 |
Non-necrotizing granulomatous inflammation | 46–74 |
Cellular pleomorphism | 43 |
Necrosis | 35 |
Thymic remnants | 27 |
Prominent cystic changes | 8 |
Intercellular edema | 4 |
Syncytiotrophoblasts | 4 |
Mean mitotic count/ten high-power fields | 4.4 (range, 0–16) |
Fig. 8.2
Seminoma arising in the thymus. (a) Lymphoid tissue with germinal centers contains scattered nests of atypical cells (arrows). (b) These irregular nests are comprised of cohesive atypical epithelioid cells, many of which have clear cytoplasm (c) and others have more eosinophilic cytoplasm (d). Many tumor cells have prominent nucleoli. Occasional Hassall corpuscles within the lymphoid tissue suggest a background of thymic parenchyma (e). The neoplastic cells are positive for OCT4 (f) and CD117 (g) and are negative for CD30 (h) and keratin AE1/AE3 (i). Magnification × 12.5 (a), 100 (b), 400 (c–i)
Fig. 8.3
Seminoma. (a) In this case there are only occasional single tumor cells or small clusters of tumor cells in a lymphoid background with prominent lymphoid hyperplasia. On low magnification these tumor cells are difficult to identify and might be easily missed (arrow). (b) On higher magnification small nests of tumor cells are identified. These tumor cells have clear cytoplasm and some have prominent nucleoli. The neoplastic cells are highlighted by OCT3/4 (c), CD117 (d), and PLAP (e). Magnification × 20 (a), × 400 (b–e)
Fig. 8.4
Thymoma, WHO type B2. (a) On gross examination, there is a well-circumscribed, tan, lobulated tumor with intervening fibrous septa. (b) The lobulated architecture is also apparent on low-power microscopy that reveals hypercellular lobules that are separated by fibrous septa. (c) On high magnification there is a mixture of larger epithelial tumor cells and small lymphocytes. Magnification × 12.5 (b), × 400 (c)
In mediastinal seminomas the neoplastic cells can sometimes be arranged in cell nests that are separated by thin fibrovascular septa. The fibrovascular septa will characteristically be infiltrated by a large number of lymphocytes. Foci with giant cells of the syncytiotrophoblast type have been observed in <5 % of mediastinal GCTs [23]. A few cases of anaplastic seminoma have also been reported in the anterior mediastinum [74]. Rarely, in the mediastinum, seminomas can be associated with another non-GCT such as primary leiomyosarcoma [75].
Most seminomas (96 %) of the mediastinum harbor chromosome 12p abnormalities, including 12p amplification (87 %) or isochromosome 12p (65 %) [73].
8.6.3 Other Non-seminomatous Mediastinal Germ Cell Tumors
Other non-seminomatous mediastinal GCTs are rare (Table 8.1).
The histopathologic characteristics of non-seminomatous mediastinal GCTs such as embryonal carcinoma, mixed germ cell tumors, yolk sac tumors (Fig. 8.5), and choriocarcinomas are similar to their gonadal counterparts and are described elsewhere in this book.
Fig. 8.5
Yolk sac tumor. (a) This tumor shows a predominant solid growth pattern with a few glandular structures. (b) Schiller-Duval bodies are identified. (c) The neoplastic cells are round to oval with clear to eosinophilic cytoplasm, open chromatin, and prominent nucleoli. The tumor cells express keratin AE1/AE3 (d), some express weakly CD117 (e), and they are negative for PLAP (f) and OCT4 (g). Magnification × 40 (a), × 400 (b–g)
8.6.4 Sarcomatoid Component of Mediastinal Germ Cell Tumors
Sarcomatous differentiation of GCT is most frequently seen in the mediastinum and may occur in association with mature teratomas or, less commonly, with other malignant GCTs including immature teratoma, choriocarcinoma, yolk sac tumor, and seminoma [76]. The most common type of heterologous differentiation is rhabdomyosarcoma; other sarcomatous components include angiosarcoma, leiomyosarcoma, glioblastoma multiforme, malignant peripheral nerve sheath tumor, epithelioid hemangioendothelioma, and undifferentiated sarcoma (Fig. 8.6) [76]. Cases with components of chondrosarcoma, osteosarcoma, liposarcoma, malignant fibrous histiocytoma, primitive neuroectodermal tumor, and neuroblastoma have also been reported. Any somatic-type malignancy should be reported because PMGCTs with sarcomatous differentiation are unresponsive to conventional GCT therapy and their prognosis is dismal [76]. An estimate of the involved area may also be helpful (see also Chapter 12).
Fig. 8.6
Spindle cell sarcoma arising in teratoma. (a) Low magnification view reveals a neoplastic spindle cell proliferation with focal osteoid (thick arrow). A cyst lined by glandular epithelium (thin arrow) and another cyst lined by bland cuboidal epithelium (star) are suggestive of a teratoma. (b, c) High-power view shows pleomorphic spindle cells with dark nuclear chromatin consistent with a spindle cell sarcoma. Magnification × 40, (a), × 400 (b, c)
Because of the poor prognosis of patients with PMGCT with sarcomatous component, its distinction from immature mesenchyme in an immature teratoma is critical. In general, the spindled component of immature teratoma is cytologically bland, is relatively monomorphic, and is typically condensed around teratomatous glands with a concentric, swirling growth pattern. In contrast, sarcomatous differentiation is characterized by an expansile and architectural complex (i.e., intersecting fascicles or storiform pattern) growth with infiltration of the surrounding tissues; usually has a greater degree of nuclear pleomorphism and hyperchromasia, obvious mitotic activity, and obvious malignant heterologous differentiation; and lacks intimately admixed glands. Rhabdomyoblasts can be distinguished from hepatoid yolk sac tumor or other eosinophilic mimickers by the demonstration of expression of smooth muscle markers including desmin and myogenin. In contrast to stromal overgrowth, sarcomatous differentiation shows independent growth by virtue of replacing teratomatous glands or other germ cell elements, thus forming an area of pure sarcoma [77].
Patients with PMGCT with sarcomatous component appear to have a worse prognosis than their gonadal counterparts. Malagon et al. [76] showed that only 18 % of patients with PMGCT with sarcomatous component were alive at 12–42 months, while 82 % had died from disease between 1 and 37 months. Patients with mediastinal tumors usually die due to local compromise of vital structures. In contrast 56 % of patients with testicular GCT with sarcomatous component were alive at 1–72 months, and only 44 % had died from disease between 5 and 96 months. Despite their better prognosis, testicular GCTs with sarcomatous component have a greater tendency for metastases (75 %) compared to mediastinal tumors (18 %). These differences in tumor behavior and prognosis may be due to location and size of the lesion and their resectability. In the study by Malagon et al. [76], the majority of extragonadal tumors were larger and bulkier than the gonadal lesions and were more commonly excised with positive margins. Moreover, the mediastinal location allows tumors to grow much larger before becoming symptomatic, so increasing the potential for malignant transformation. Because of the large size, the majority of PMGCTs were extensively infiltrative at the time of surgery making complete resection very difficult.
8.7 Ancillary Studies
Ancillary studies might be utilized to distinguish PMGCT from other primary or secondary mediastinal tumors. Immunohistochemical and cytogenetic studies are most helpful.
8.7.1 Immunohistochemical Studies (Table 8.3)
In general, the immunophenotype of PMGCT is similar to its gonadal counter. However, there are some significant differences in the expression of some antigens, especially on tumor cells of seminomas [78]. For instance, in a study by Suster et al. [78], the low molecular weight keratin CAM 5.2, which shows a strong dot-like paranuclear staining pattern in seminomas, is expressed in 80 % of mediastinal seminomas but only in 20 % of testicular seminomas. Similarly, PLAP is expressed in 92.5 % of mediastinal seminomas (Fig. 8.3) but only in 50 % of testicular seminomas.
Table 8.3
Immunophenotype of mediastinal germ cell tumors and their mimickers [Frequency (% positive cases)]
Immunostain | Seminoma | Embryonal carcinoma | Yolk sac tumor | Teratoma | Choriocarcinoma | Lung adenocarcinoma | Small cell carcinoma | Thymic carcinoma | Malignant mesothelioma | NUT midline carcinoma |
---|---|---|---|---|---|---|---|---|---|---|
100 | 100 | 0 | 0 | 0 | N/Aa | N/A | 0 | 0 | 0 | |
100 | 82–100 | 38 | 0 | 0 | 0 | N/A | N/A | N/A | 0 | |
75–100 | 77–100 | 30–59 | 43 | 0 | 17 | 82 | 80–86 | 5 | 0–25 | |
100 | 97 | 100 | 29 | 0 | N/A | N/A | 0 | N/A | 0 | |
0 | 0 | 56–100 | N/A | 0 | 60b | N/A | N/A | N/A | 0 | |
3 | 33 | 0 | 10–60 | 100 | 7–60 | 0 | 0 | 0 | 0 | |
43–100 | 59 | 40 | 0 | 0 | 25–67 | N/A | 0 | 15 | 0 | |
96–100 | 35 | 3 | N/A | N/A | 7 | N/A | N/A | 96 | N/A | |
48–80 | 100 | 100 | 100 | 100 | 100 | 100 | 100c | 100 | 73 | |
0–43 | 100 | 100 | 100 | 100 | 100 | 50–100 | 100 | 100 | 31 | |
0–39 | 0 | N/A | N/A | N/A | 25–82 | 0 | 100d | 89e | N/A | |
39–41 | 100 | N/A | 97 | N/A | 79–100 | 43 | 80 | 65–81 | 40 | |
0 | 0 | 0 | 0–100 | N/A | 10 | 0 | N/A | 0 | 0 | |
2–9 | 33 | 29 | 100f | 54 | 95–100 | N/A | 100 | 96e–98 | 71 | |
0 | N/A | N/A | N/A | N/A | 10 | 0 | 20–70 | 0–12 | 33 | |
0–2 | 73–100 | 0–11 | 40g | 0 | 0 | 0 | N/A | 0 | 12 | |
0 | 0 | 0 | 50 | N/A | 57–89 | 85–95 | 0 | 0 | 33 | |
9 | 0 | N/A | 0 | 0 | 4–10 | 41 | N/A | 87–100 | N/A | |
N/A | N/A | 0 | N/A | N/A | 0 | N/A | 5 | 58–93 | 0 | |
19–71%h | 0 | 5 | N/A | N/A | N/A | N/A | 6i | N/A | 100 |
OCT4 has a high sensitivity and specificity for seminoma and embryonal carcinoma [79–81]. Nearly 100 % of seminomas and embryonal carcinomas show nuclear reactivity with OCT4, and the specificity seems superior to other available markers (Fig. 8.2f) [79–81].
Keratins can be expressed in 39–80 % of mediastinal seminomas and therefore might present a pitfall mimicking carcinoma [51, 77, 78]. However, in most cases, the epithelial markers highlight only a small proportion of tumor cells with variable intensities [73].
Strong membranous CD117 (kit) immunoreactivity has been reported in 75–100 % of seminomas (Figs. 8.2g and 8.3d) [82]. However, in the mediastinum, CD117 is not specific to seminomas because it is also expressed in other non-germ cell tumors including small cell carcinoma and adenocarcinomas of the lung [83] and thymic carcinomas [84, 85]. In addition, embryonal carcinoma, yolk sac tumor, and choriocarcinoma may show some degree of weak CD117 reactivity (Fig. 8.5e).
CD30 is expressed in over 80 % of embryonal carcinomas. However, CD30 is also expressed in various hematopoietic malignancies which commonly occur in the mediastinum such as mediastinal large B-cell lymphoma or Hodgkin lymphoma (Fig. 8.7) [86] but also occasionally in yolk sac tumors and rarely seminoma [78].
Fig. 8.7
Classical Hodgkin lymphoma, nodular sclerosing type. (a) A pneumonectomy specimen contains a 6.0 cm left centrally located, ill-defined, lobulated, yellow-white lung mass. (b) On low-power microscopy, there is a fibrotic, vaguely lobulated mass in a central location (note residual hyaline cartilage of a large airway in the upper left and right corners). (c). On high power, scattered large, multinucleated Reed-Sternberg cells (arrow) are apparent in a background of a mixed inflammatory background predominantly comprised of lymphocytes, eosinophils, macrophages, and plasma cells. The large atypical cells mark with CD30 (d). Magnification, × 12.5 (b), × 400 (c, d)
AFP is not a reliable marker for yolk sac tumors because of its low sensitivity [87]. Furthermore, AFP can be expressed in 60 % of hepatoid adenocarcinomas of the lung [88]. Serum evaluation of AFP and [beta]-human chorionic gonadotropin (beta-HCG) is frequently more sensitive than immunohistochemistry. However, beta-HCG is also not entirely specific to GCT and can be seen in 10–60 % of adenocarcinomas of the lung [89, 90].
Although placental-like alkaline phosphatase (PLAP) has traditionally been the marker of choice for GCTs (mostly seminoma), in the setting of an “undifferentiated” neoplasm in the mediastinum, its lack of sensitivity, generally high background staining, and the development of newer antibodies have rendered this stain less useful in current diagnostic practice.
8.7.2 Cytogenetic Studies
Bosl et al. [11] found that the isochromosome of chromosome 12 [i(12p)] as evaluated by FISH studies is a useful marker for GCT in males. This was further confirmed in a study by Sung et al. [73] that showed abnormalities of chromosome 12p including 12p amplification and i(12p) in 22 out of 23 cases of mediastinal seminoma. Chaganti et al. [59] performed karyotypic analysis of 13 PMGCT and observed characteristic i(12p) in 69 % cases (9/13).
8.8 Differential Diagnosis of Mediastinal Germ Cell Tumors (Tables 8.4 and 8.5)
8.8.1 Germ Cell Tumors Metastatic to the Mediastinum
Although rare, testicular GCT can metastasize to the mediastinum [91]. However, in most mediastinal GCTs, examination of the testes fails to reveal a primary tumor. For instance, in 16 patients with extragonadal GCTs, the testicles did not have any palpable lesion [92]. However, occult testicular tumors were later identified in 10 of 12 patients with retroperitoneal GCT but in none of the mediastinal GCT. Therefore, not all testicular GCTs can be identified by palpation alone. In a study of 20 autopsy cases of mediastinal GCT, Luna and Valenzuela-Tamaris [93] identified only two cases in which the testes contained either an occult tumor or a well-defined testicular scar. Moreover, of 78 autopsies of patients with testicular GCTs, no autopsy showed solely metastases in the anterior mediastinum without involvement of other mediastinal lymph nodes (middle/posterior) [94]. In another such study of 220 cases of metastasizing testicular tumors, no metastases were documented in the mediastinum [95]. These studies emphasize that testicular GCT can metastasize to the mediastinum, but that appears to be rather exceptional, and GCTs in the mediastinum are usually of primary origin. However, the possibility of mediastinal GCT of testicular origin exists and must be excluded. A careful review of the past medical history, physical examination, and imaging studies are necessary to distinguish between primary and metastatic disease. Moreover, retroperitoneal tumor metastases are virtually always present in cases of testicular seminoma that have metastasized to the mediastinum.
Table 8.4
Features that might facilitate the distinction between mediastinal germ cell tumors and their mimickers
Diagnosis | Distinguishing feature(s) |
---|---|
Seminoma | Lymphocytic infiltrate |
Cyst formation possible | |
Intense staining for OCT4 | |
Isochromosome 12p abnormalities by FISH | |
Thymoma | Lobulated architecture |
OCT4 negative | |
Thymic carcinoma | OCT4 negative |
NUT carcinoma | NUT immunostain shows a speckeled nuclear staining pattern |
t(15;19) by FISH, RT-PCR | |
Metastatic carcinoma | Morphologic features |
Immunophenotype | |
Synovial sarcoma | t(X;18), FISH, RT-PCR |
Lymphoma | Immunophenotype |
Flow cytometry | |
B-cell or T-cell receptor rearrangement studies |
Table 8.5
Differential diagnosis of tumors that might occur in the mediastinum by morphologic pattern
Morphologic pattern | ||||
---|---|---|---|---|
Epithelial-lined cyst | Mixed epithelial and spindled | Poorly differentiated | Papillary | Clear cells |
Mature teratoma | Immature teratoma | Embryonal carcinoma | Embryonal carcinoma | Seminoma |
Seminoma | Yolk sac tumor | Seminoma | Yolk sac tumor | Yolk sac tumor |
Thymic cyst | Malignant mesothelioma | Malignant mesothelioma | Malignant mesothelioma | Thymic clear cell carcinoma |
Enteric cyst | Sarcomatoid carcinoma | Thymic carcinoma | Myxopapillary ependymoma | Metastatic Muellerian clear cell carcinoma |
Bronchogenic cyst | Synovial sarcoma | Lymphoma | Metastatic renal cell carcinoma | |
Epidermal inclusion cyst | Pleuropulmonary blastoma | NUT carcinoma, t(15;19) | ||
Dermoid cyst | Congenital peribronchial myofibroblastic tumor | Epithelioid angiosarcoma | ||
Branchial cleft cyst | Pulmonary hamartoma | Lung adenocarcinoma | ||
Thyroglossal duct cyst | Thymoma (WHO type AB) | Melanoma | ||
Epidermoid cyst | Spindle cell epithelial tumor with thymus-like differentiation (SETTLE) | Carcinoma showing thymus-like differentiation (CASTLE) | ||
Metastatic Wilms’ tumor |
8.8.2 Thymic Cysts
Thymic cysts may be unilocular or multilocular and can potentially mimic teratoma or seminoma. The unilocular cysts, remnants of the third branchial pouch-derived thymopharyngeal duct, may be lined by cuboidal, columnar, or sometimes squamous epithelium and contain thymic tissue within the cyst wall (Fig. 8.8) [96]. Multilocular cysts are acquired cystic ductular dilatations due to inflammatory reaction of the thymic parenchyma and are frequently lined by squamous epithelium, but cuboidal or ciliated columnar linings are also described [97, 98]. Cholesterol granulomas and chronic inflammatory infiltrate are commonly found in the cyst wall of multiloculated thymic cysts. The lack of heterologous elements and the presence of thymic tissue underlying the epithelium should aid in the distinction from teratoma. However, seminoma and yolk sac tumors should be carefully excluded because these tumors can show similar cystic changes in the thymus as seen in a multiloculated thymic cyst [50]. Awareness of this secondary thymic change and thorough sampling are critical in excluding an associated GCT.
Fig. 8.8
Thymic cyst. (a) Cystic structures are surrounded by a lymphoid and adipose tissue. (b) The cysts are lined by bland cuboidal cells. (c) Benign thymic parenchyma with a Hassall corpuscle is also present in the wall of the cyst. Magnification × 20 (a), × 200 (b, c)
8.8.3 Enteric Cysts
Enteric cysts are usually found in children and adolescents and are almost exclusively located in the posterior mediastinum (paraesophageal and gastroesophageal) [99–101]. The cyst wall contains a double layer of smooth muscle and can be lined by simple or pseudostratified columnar, squamous, or gastric mucosa.
8.8.4 Bronchogenic Cysts
Bronchogenic cysts, congenital anomalies of foregut origin, can be found in any mediastinal compartment and in any age group [101, 102]. They may closely mimic mature teratomas because they are comprised of respiratory epithelium, smooth muscle, and mature cartilage or mucous glands. Cysts with well or moderate architectural differentiation toward normal tracheobronchial structures, presence of respiratory-type epithelium, lack of enteric-type epithelium, immature elements, atypia, and tumor necrosis favor bronchogenic cyst [103]. The presence of CK7 expression in the absence of staining with CDX2 further supports bronchogenic cyst. In contrast, teratomas have a mixed enteric and respiratory epithelium, and the majority of the glands express CK7, CK20, CDX2, and TTF-1. Moreover, coexpression of CDX2 and TTF-1 was only found in teratoma [103].
8.8.5 Meningocele
Meningoceles are posterior mediastinal cysts which communicate with meninges. In general they occur in infants and children [104]. The clinical/radiographic features are usually characteristic. Microscopically, they might show various amounts of neural tissue and calcification and should not be confused with teratoma.
8.8.6 Pleuropulmonary Blastoma
In children, pleuropulmonary blastoma (PPB) can potentially mimic a GCT because of its biphasic appearance and heterologous mesenchymal differentiation [105, 106]. It can be cystic and/or solid and has sarcomatoid characteristics. It is usually found in the lung but occasionally can be identified in the pleura. The cysts are typically lined by respiratory or cuboidal epithelium and lack the squamous, gastrointestinal, or neuroglial lining often seen in teratoma (Fig. 8.9). The primitive spindled cells of PPB often resemble embryonal rhabdomyosarcoma or fibrosarcoma, patterns which are unusual in teratoma but might be present as sarcomatoid component in other GCTs. Heterologous elements such as cartilage may rarely be seen in PPB. The cyst lining together with the absence of other organized elements helps to distinguish this rare malignant tumor from a primary intrapulmonary teratoma.
Fig. 8.9
Pleuropulmonary blastoma. (a) Low magnification reveals a multicystic tumor. (b) The cystic spaces are lined by respiratory epithelium. A population of primitive malignant small round blue cells is beneath the cyst lining. Magnification × 12.5 (a), 400 (b)
8.8.7 Sarcomatoid Carcinoma
Sarcomatoid carcinomas of the lung are a broad spectrum of poorly differentiated non-small cell carcinomas that contain a sarcoma or sarcoma-like component (Fig. 8.10) [107]. The closest mimics of immature teratoma include pleomorphic carcinoma, carcinosarcoma, and pulmonary blastoma. Pleomorphic carcinoma contains a component of morphologically typical non-small cell carcinoma (i.e., squamous cell carcinoma, adenocarcinoma, or large cell carcinoma) admixed with a malignant spindle cell component lacking a specific line of heterologous differentiation. The obvious non-small cell lung carcinoma component should allow distinction from immature teratoma or PMGCT with sarcomatoid component in most cases. Carcinosarcoma, like pleomorphic sarcoma, is comprised of non-small cell carcinoma, but, in contrast to pleomorphic sarcoma, also contains a differentiated sarcomatous component (e.g., chondrosarcoma, rhabdomyosarcoma, osteosarcoma) (Fig. 8.11) [77]. Again, the presence of typical non-small cell lung carcinoma should allow the distinction in most cases. The closest histologic mimic of teratoma is the pulmonary blastoma [108–110]. Despite the name, this is a tumor predominantly of adults characterized by an admixture of fetal-type adenocarcinoma (tubules lined by pseudostratified columnar, nonciliated epithelium with clear to lightly eosinophilic cytoplasm) and embryonic mesenchyme, both of which resemble fetal lung between 10 and 16 weeks of gestation [111]. The glands often have supranuclear or subnuclear vacuoles and sometimes show squamous morular metaplasia creating an endometrioid appearance. The condensation of the spindle cell component around the glands may closely mimic immature teratoma, especially if heterologous differentiation is present. Recognition of the typical fetal-type gland morphology is key to this distinction.
Fig. 8.10
Sarcomatoid carcinoma. (a) Low-power view shows a hypercellular malignancy in a fibrotic background. Malignant spindle cells are growing in sheets or along preformed structures, in this case leading to thickening of the pulmonary interalveolar septum (b) Neoplastic spindle cells have large nuclei with irregular borders and dark chromatin (c) and mark with keratin AE1/AE3 (d) Magnification × 20 (a), 100 (b, d), 400 (c)
Fig. 8.11
Carcinosarcoma. (a) Low-power view shows a biphasic neoplasm that is comprised of an epithelial (glandular, squamous, and undifferentiated) and a mesenchymal (malignant cartilage) component. High-power microscopy reveals neoplastic glands (b), focal squamous differentiation (c), sheets of neoplastic epithelioid cells to suggest undifferentiated carcinoma (d), and neoplastic cartilage (e). Magnification × 12.5 (a), × 200 (b–e)